Why the study?
Does enteral linezolid allow for effective completion of therapy without rehospitalization in pediatric intensive care unit patients with gram-positive infections?
Does enteral linezolid allow for effective completion of therapy without rehospitalization in pediatric intensive care unit patients with gram-positive infections?
Enteral linezolid may offer an effective and safe alternative to intravenous vancomycin for treating gram-positive infections in pediatric ICU patients, avoiding the need for prolonged vascular access.
No takes yet. Share an insight, caveat, or question.
May support enteral linezolid in pediatric ICU gram-positive infections; hypothesis-generating, needs RCTs before practice change.
Ehab S ELDesoky (2006) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: